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1  | INTRODUC TION
Myxedema coma is an emergency presentation of hypothyroidism, 
leading to altered mental status, hypothermia, and cardiopulmo‐
nary dysfunction related to slowing of function in multiple organs. 
Myxedema coma is rare with an incidence rate of only 0.22 per 1 
million people per year, and it occurs almost exclusively in persons 
60 years of age or older with a female predominance (80%).1 The 
mortality rate of the disease was reported to be as high as 25%‐52%.2 
Among symptoms associated with myxedema coma, cardiovascular 
and pulmonary manifestations tend to be severe and related to a 
high mortality rate.3,4 We herein report a rare case of myxedema 
coma accompanied by sick sinus syndrome (SSS) as a cardiovascu‐
lar manifestation and hypercapnic respiratory failure as a pulmo‐
nary manifestation, both of which were reversible and successfully 
treated with levothyroxine.
2  | C A SE PRESENTATION
An 87‐year‐old Japanese woman with a history of hypertension 
and dyslipidemia was referred to our hospital because of bradycar‐
dia and respiratory failure. Fourteen days prior to admission to our 
hospital, the patient developed dyspnea and altered mental status, 
and she was admitted to the previous hospital. On physical examina‐
tion, her height, body weight, and BMI were 146.5 cm, 41.7 kg, and 
19.4 kg/m2, respectively. Oxygen saturation was 72% on room air, 
respiratory rate was 12 breaths per minute, body temperature was 
36.9C, and Glasgow Coma Scale score was 12 (E3V4M5). Arterial 
blood gas showed pH 7.308, pCO2 of 92.2 mm Hg, and bicarbonate 
of 45.2 mmol/L. Laboratory findings revealed severe hypothyroid‐
ism with a thyroid‐stimulating hormone (TSH) level of 40.56 µIU/mL 
(normal range: 0.54‐4.26), free T4 (FT4) of 0.11 ng/dL (normal range: 
0.71‐1.52), and free T3 of 0.60 pg/mL (normal range: 2.30‐4.00). 
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Abstract
Myxedema coma is an emergency presentation of hypothyroidism, and cardiopul‐
monary manifestations of the disease are related to a high mortality rate. We herein 
report a case of myxedema coma accompanied by sick sinus syndrome requiring tem‐
porary cardiac pacing and hypercapnic respiratory failure in an 87‐year‐old woman. 
This case is unique because both of the cardiac and pulmonary manifestations were 
reversible and successfully treated with thyroid hormone replacement. Our case in‐
dicates that early detection of the condition and administration of levothyroxine are 
essential to improve the life‐threatening condition and avoid invasive treatment such 
as permanent pacemaker implantation or intubation.
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Antithyroid peroxidase antibody and antithyroglobulin antibody 
were negative, and thyroglobulin was 134 ng/mL (normal range: 
0‐33.0). Adrenal insufficiency was ruled out as the serum cortisol 
level in the morning was 23.0 µg/dL. Electrocardiography (ECG) 
showed sinus bradycardia with first‐degree atrioventricular (AV) 
block with a heart rate (HR) of 53 beats/min (bpm). A chest X‐ray 
showed enlargement of the cardiac silhouette and bilateral costo‐
phrenic angle blunting (Figure 1). Echocardiography showed a left 
ventricular ejection fraction of 65% without pericardial effusion. 
After being admitted to the previous hospital, she had bradycar‐
dia, with a HR between 36 and 40 bpm, which lasted for several 
hours. Her clinical features along with laboratory findings strongly 
suggested myxedema coma accompanied by SSS and hypercapnic 
respiratory failure.
Her clinical course is shown in Figure 2. Treatment with oral 
levothyroxine of 150 µg per day was initiated via a nasogastric tube, 
and a transvenous temporary pacemaker was inserted via the right 
femoral vein with a ventricular rate of 60 bpm. Noninvasive positive 
pressure ventilation (NPPV) was administered because of her respi‐
ratory failure. On day 9, the patient developed fever and chills, and 
two sets (from 4 bottles) of blood cultures tested positive for meth‐
icillin‐resistant Staphylococcus epidermidis (MRSE). Transthoracic 
echocardiography showed no vegetation in heart valves. Based on 
the diagnosis of MRSE bacteremia without any involvement of other 
sites, intravenous administration of vancomycin was initiated and 
discontinued 2 weeks after confirmation of negative blood culture. 
The patient was referred to our hospital for further evaluation and 
treatment. On admission to our hospital, both TSH and free T4 were 
normalized. Since her hypercapnic respiratory failure had been im‐
proved, NPPV was discontinued. Because her HR was stable around 
50 bpm without cardiac pacing, temporary pacemaker was also dis‐
continued. Her cardiomegaly on chest X‐ray improved with hormone 
replacement therapy. After removing temporary pacemaker, the pa‐
tient did not show any symptoms associated with bradycardia such 
as loss of consciousness or heart failure. On day 45, she was trans‐
ferred to the previous hospital for rehabilitation.
3  | DISCUSSION
We report a case of severe hypothyroidism in an elderly woman 
that caused SSS requiring temporary cardiac pacing and hypercap‐
nic respiratory failure that was treated with NPPV. Our case fulfills 
the diagnostic criteria for myxedema coma (3rd draft) provided by 
the Japan Thyroid Association, with hypothyroidism, altered mental 
status, hypoventilation, and cardiac dysfunction.5 This case is also 
unique with respect to the clinical course, in which those cardiopul‐
monary dysfunctions were reversible to some extent with thyroid 
hormone replacement therapy.
Cardiovascular complications with severe hypothyroidism in‐
clude sick sinus syndrome, AV block, decreased myocardial con‐
tractility, low cardiac output, and hypotension. Myxedema coma 
requiring temporary or permanent pacemaker implantation is rare, 
and the requirement of the procedure is mainly due to second‐de‐
gree or complete AV block. Although those conditions usually need 
permanent pacemaker insertion even after normalization of thy‐
roid status, reversible cases have been reported.6 To cite an exam‐
ple, Waseem et  al reported a case of myxedema coma with severe 
bradycardia and high‐grade AV block that was successfully treated 
with thyroxine hormone replacement without requiring cardiac 
pacemaker placement.7 Schoenmakers et  al reported a 90‐year‐old 
patient who presented with complete AV block because of severe 
hypothyroidism, in whom AV conduction was restored after sup‐
pletion with levothyroxine.8 To the best of our knowledge, this is 
the first reported case of hypothyroidism‐induced SSS requiring a 
temporary pacemaker successfully avoiding permanent pacemaker 
with hormone replacement therapy. Our case, together with pre‐
vious cases, suggests that SSS accompanying myxedema coma can 
be improved by treatment of hypothyroidism with permanent pace‐
maker implantation, thereby being avoidable, as in our case. Since 
myxedema coma mainly affects elderly people, early recognition and 
treatment with levothyroxine are important for avoiding permanent 
pacemaker implantation, which is a relatively invasive procedure.
Hypercapnic respiratory failure is another emergency complica‐
tion of myxedema coma. In patients with myxedema crisis, hypox‐
emia is observed in 80%, while hypercapnia in 54% of the patients.9,10 
Hypoventilation with respiratory acidosis primarily results from cen‐
tral depression of ventilatory drive and decreased responsiveness to 
hypoxia and hypercapnia.11 Other contributing factors of respiratory 
failure because of hypothyroidism include respiratory muscle weak‐
ness, mechanical obstruction by a large tongue and pharynx, obesity, 
diaphragmatic dysfunction, and sleep apnea.11,12 These respiratory 
abnormalities respond to thyroid hormone replacement, as observed 
in our case. Although hypoventilatory respiratory failure does not 
tend to be associated with endocrine diseases, hypothyroidism should 
F I G U R E  1   A chest X‐ray showed enlargement of the cardiac 
silhouette and bilateral costophrenic angle blunting
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be included as a differential diagnosis in elderly patients if no obvious 
cardiopulmonary or central nervous system disease explains the clin‐
ical presentation because myxedema coma occurs in elderly popula‐
tions, especially those older than 60 years of age.13
In conclusion, we report a case of myxedema coma in an elderly 
woman that was accompanied by SSS and hypercapnic respiratory 
failure, which were successfully treated with thyroid hormone re‐
placement. Since the mortality rate of the disease is high possibly 
because of its cardiopulmonary complications, early detection of the 
condition and administration of levothyroxine, intravenous levothy‐
roxine if available, are essential to improve the life‐threatening con‐
dition and avoid invasive treatment such as permanent pacemaker 
implantation or intubation.
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F I G U R E  2   The patient's clinical 
course and transition of laboratory data 
including pCO2 of arterial blood gas, 
free T4 (FT4), and thyroid‐stimulating 
hormone (TSH). Since blood culture 
(BC) examination revealed methicillin‐
resistant Staphylococcus epidermidis 
(MRSE), intravenous vancomycin 
(VCM) was administered. Noninvasive 
positive pressure ventilation (NPPV) was 
discontinued on day 16, and temporary 
cardiac pacing was discontinued on day 39
